ADAR1 Capital Management, LLC

Position in TSHA — Taysha Gene Therapies, Inc.

CIK 1940272 AUSTIN, TX

Position in TSHA

as of Mar 31, 2026 · filed May 18, 2026 Compact

Position Value

$13,318,047

-$408,902 QoQ

Shares Held

2,979,429

+19.4% QoQ

Ownership

1.04%

of shares outstanding

% of Portfolio

0.84%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Dec 2023

10 quarters on record

Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Healthcare · as of Mar 31, 2026

ADAR1 Capital Management, LLC holds $1,363,006,285 across 212 Biotechnology names. TSHA ranks #23 (1.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	ABVX	Abivax S.A.	1,394,019	$155,224,015
2	PTGX	Protagonist Therapeutics, Inc	994,119	$104,780,142
3	ROIV	Roivant Sciences Ltd.	3,285,906	$91,019,596
4	IMVT	Immunovant, Inc.	2,679,010	$66,546,608
5	TERN	Terns Pharmaceuticals, Inc.	914,699	$48,222,931
6	CYTK	Cytokinetics Inc	632,556	$41,691,765
7	CRNX	Crinetics Pharmaceuticals, Inc.	1,139,331	$41,380,501
8	DNLI	Denali Therapeutics Inc.	1,871,455	$35,931,936

10 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$13,318,047	2,979,429	+19.4%	Shares	Sole	2026-05-18
2025-12-31	$13,726,949	2,495,809	-12.0%	Shares	Sole	2026-02-18
2025-09-30	$9,272,673	2,835,680	-5.8%	Shares	Sole	2025-11-14
2025-06-30	$6,952,799	3,009,870	+182.3%	Shares	Sole	2025-08-14
2025-03-31	$1,482,169	1,066,309	+500.0%	Shares	Sole	2025-05-15
2024-12-31	$307,433	177,707	-29.3%	Shares	Sole	2025-02-13
2024-09-30	$505,314	251,400	+0.2%	Shares	Sole	2024-11-14
2024-06-30	$561,792	250,800	+476.6%	Shares	Sole	2024-08-13
2024-03-31	$124,845	43,500	-79.2%	Shares	Sole	2024-05-15
2023-12-31	$369,930	209,000	—	Shares	Sole	2024-02-14
No filing history on record for this holder in this stock.